Download PDF
Thromb Haemost 2000; 84(04): 635-637
DOI: 10.1055/s-0037-1614079
Review Article
Schattauer GmbH

Homozygous 2bp Deletion in the Human Factor VII Gene: A Non-Lethal Mutation that Is Associated with a Complete Absence of Circulating Factor VII

Flora Peyvandi
1   From the Haemophilia Centre and Haemostasis Unit, Department of Haematology, Royal Free & University College Medical School, Royal Free Campus, London, UK
2   Angelo Bianchi Bonomi Haemophilia and Thrombosis Center, IRCCS Maggiore Hospital and University of Milan, Italy
,
Pier M. Mannucci
2   Angelo Bianchi Bonomi Haemophilia and Thrombosis Center, IRCCS Maggiore Hospital and University of Milan, Italy
,
P. Vince Jenkins
1   From the Haemophilia Centre and Haemostasis Unit, Department of Haematology, Royal Free & University College Medical School, Royal Free Campus, London, UK
,
Anselm Lee
3   Department of Paediatrics, Tuen Mun Hospital, New Territories, Hong Kong, China
,
Raffaella Coppola
2   Angelo Bianchi Bonomi Haemophilia and Thrombosis Center, IRCCS Maggiore Hospital and University of Milan, Italy
,
David J. Perry
1   From the Haemophilia Centre and Haemostasis Unit, Department of Haematology, Royal Free & University College Medical School, Royal Free Campus, London, UK
› Author AffiliationsThis work was supported by the Katharine Dormandy Trust for Haemophilia and Allied Disorders and the Fondazione Angelo Bianchi Bonomi. We are grateful to Professor EGD Tuddenham for helpful suggestions and comments.
Further Information

Publication History

Received 29 September 1999

Accepted after revision 02 May 2000

Publication Date:
11 December 2017 (online)

    Permissions and Reprints

Summary

We report the case of a 5-year-old boy with severe factor VII deficiency. The affected child presented at the age of 8 months and again at 18 months with bleeding from the gastrointestinal tract but the diagnosis of factor VII deficiency was not made until the age of 3 years. He was treated with fresh frozen plasma and subsequently factor VII concentrates and to date remains well. To identify the causative mutation, the factor VII gene was screened by SSCP and direct sequence analysis. A single homozygous 2bp deletion (-CT) mutation was identified in exon 1a removing nucleotides 27/28 (codons 52/53). Both parents, who were first cousins, were heterozygous for the mutation. The mutation located in the prepropeptide of factor VII, results in a complete absence of factor VII in plasma. This case indicates that a complete absence of plasma factor VII is not necessarily a lethal condition.

Key words

FVII - mutation - deletion
 

  • References

  • 1 Bajaj SP, Rapaport SI, Brown SF. Isolation and characterization of human factor VII. Activation of factor VII by factor Xa. J Biol Chem 1981; 256: 253-9.
    PubMedGoogle Scholar
  • 2 Hagen FS, Gray CL, O’Hara P, Grant FJ, Saari GC, Woodbury RG. et al. Characterization of a cDNA coding for human factor VII. Proc Natl Acad Sci USA 1986; 83: 2412-6.
    CrossrefPubMedGoogle Scholar
  • 3 O’Hara PJ, Grant FJ, Haldeman BA, Gray CL, Insley MY, Hagen FS. et al. Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation. Proc Natl Acad Sci USA 1987; 84: 5158-62.
    CrossrefPubMedGoogle Scholar
  • 4 Edgington TS, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost 1991; 66: 67-79.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Camerer E, Kolstá AB, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 1996; 81: 1-41.
    CrossrefPubMedGoogle Scholar
  • 6 Triplett DA, Brandt JT, Batard MA, Dixon JL, Fair DS. Hereditary factor VII deficiency: heterogeneity defined by combined functional and immunochemical analysis. Blood 1985; 66: 1284-7.
    PubMedGoogle Scholar
  • 7 Peyvandi F, Mannucci PF, Asti D, Abdoullahi M, Di Rocco N, Sharifian R. Clinical manifestations in 28 Italian and Iranian Patients with Severe Factor VII Deficiency. Haemophilia 1997; 03: 242-6.
    CrossrefPubMedGoogle Scholar
  • 8 McVey JH, Boswell EJ, Takamiya O, Tamagnini G, Valente V, Fidalgo T. et al. Exclusion of the First EGF Domain of Factor VII by a Splice Site Mutation Causes Lethal Factor VII Deficiency. Blood 1998; 92: 920-6.
    PubMedGoogle Scholar
  • 9 Poggio M, Tripodi A, Mariani G, Mannucci PM. Factor VII Clotting Assays: Influence of Different Thromboplastins and Factor VII Deficient plasmas. Thromb Haemost 1991; 65: 160-4.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Coppola R, Tombesi S, Valentini F, Alborali S, Albertini A, Mannucci PM. Enzyme-linked immunosorbent assay of human factor VII based upon a monoclonal antibody that recognizes the native conformation of the protein. Thromb Res 1992; 68: 283-93.
    CrossrefPubMedGoogle Scholar
  • 11 Berkner K, Busby S, Davie E, Hart C, Insley M, Kisiel W. et al. Isolation and expression of cDNAs encoding human factor VII. Cold Spring Harb Symp Quant Biol 1986; 51 Pt 1: 531-41.
    CrossrefPubMedGoogle Scholar
  • 12 Rosen ED, Chan JC, Idusogie E, Clotman F, Vlasuk G, Luther T. et al. Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. Nature 1997; 390: 290-4.
    CrossrefPubMedGoogle Scholar
  • 13 Linton MF, Pierotti V, Young SG. Reading-frame restoration with an apolipoprotein B gene frameshift mutation. Proc Natl Acad Sci USA 1992; 89: 11431-5.
    CrossrefPubMedGoogle Scholar
  • 14 Young M, Inaba H, Hoyer LW, Higuchi M, Kazazian Jr HH, Antonarakis SE. Partial correction of a severe molecular defect in hemophilia A, because of errors during expression of the factor VIII gene. Am J Hum Genet 1997; 60: 565-73.
    PubMedGoogle Scholar